Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines

Junghun Lee, Hwan Kim, Hana Yu, Jae Yoon Chung, Chang Hyun Oh, Kyung Ho Yoo, Taebo Sim, Jung Mi Hah

Research output: Contribution to journal › Article

25 Citations (Scopus)

Abstract

The synthesis of a novel series of pyrimidin-4-yl-1H-imidazol-2-yl derivatives 7, 8, 9 and their antiproliferative activities against A375P human melanoma cell line and WM3629 cell line were described. Most compounds showed superior antiproliferative activities compared to Sorafenib, the well-known RAF inhibitor. Among them, 7a exhibited potent activities on both cell lines (IC50 = 0.62 and 4.49 μM, respectively) and turned out to be a selective and potent CRAF inhibitor.

Original languageEnglish
Pages (from-to)1573-1577
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume20
Issue number5
DOIs
Publication statusPublished - 2010 Mar 1

Fingerprint

Melanoma
Cells
Derivatives
Cell Line
Inhibitory Concentration 50
imidazole
sorafenib

Keywords

  • Antiproliferative activity
  • BRAF
  • CRAF
  • Melanoma cell line
  • Pyrimidin-4-yl-1H-imidazol-2-yl derivatives
  • Selectivity

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines. / Lee, Junghun; Kim, Hwan; Yu, Hana; Chung, Jae Yoon; Oh, Chang Hyun; Yoo, Kyung Ho; Sim, Taebo; Hah, Jung Mi.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 20, No. 5, 01.03.2010, p. 1573-1577.

Research output: Contribution to journal › Article

Lee, J, Kim, H, Yu, H, Chung, JY, Oh, CH, Yoo, KH, Sim, T & Hah, JM 2010, 'Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines', Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 5, pp. 1573-1577. https://doi.org/10.1016/j.bmcl.2010.01.064
Lee J, Kim H, Yu H, Chung JY, Oh CH, Yoo KH et al. Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines. Bioorganic and Medicinal Chemistry Letters. 2010 Mar 1;20(5):1573-1577. https://doi.org/10.1016/j.bmcl.2010.01.064
Lee, Junghun ; Kim, Hwan ; Yu, Hana ; Chung, Jae Yoon ; Oh, Chang Hyun ; Yoo, Kyung Ho ; Sim, Taebo ; Hah, Jung Mi. / Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines. In: Bioorganic and Medicinal Chemistry Letters. 2010 ; Vol. 20, No. 5. pp. 1573-1577.
@article{076459977f2e4c1a84fa030498c19407,
title = "Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines",
abstract = "The synthesis of a novel series of pyrimidin-4-yl-1H-imidazol-2-yl derivatives 7, 8, 9 and their antiproliferative activities against A375P human melanoma cell line and WM3629 cell line were described. Most compounds showed superior antiproliferative activities compared to Sorafenib, the well-known RAF inhibitor. Among them, 7a exhibited potent activities on both cell lines (IC50 = 0.62 and 4.49 μM, respectively) and turned out to be a selective and potent CRAF inhibitor.",
keywords = "Antiproliferative activity, BRAF, CRAF, Melanoma cell line, Pyrimidin-4-yl-1H-imidazol-2-yl derivatives, Selectivity",
author = "Junghun Lee and Hwan Kim and Hana Yu and Chung, {Jae Yoon} and Oh, {Chang Hyun} and Yoo, {Kyung Ho} and Taebo Sim and Hah, {Jung Mi}",
year = "2010",
month = "3",
day = "1",
doi = "10.1016/j.bmcl.2010.01.064",
language = "English",
volume = "20",
pages = "1573--1577",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines

AU - Lee, Junghun

AU - Kim, Hwan

AU - Yu, Hana

AU - Chung, Jae Yoon

AU - Oh, Chang Hyun

AU - Yoo, Kyung Ho

AU - Sim, Taebo

AU - Hah, Jung Mi

PY - 2010/3/1

Y1 - 2010/3/1

N2 - The synthesis of a novel series of pyrimidin-4-yl-1H-imidazol-2-yl derivatives 7, 8, 9 and their antiproliferative activities against A375P human melanoma cell line and WM3629 cell line were described. Most compounds showed superior antiproliferative activities compared to Sorafenib, the well-known RAF inhibitor. Among them, 7a exhibited potent activities on both cell lines (IC50 = 0.62 and 4.49 μM, respectively) and turned out to be a selective and potent CRAF inhibitor.

AB - The synthesis of a novel series of pyrimidin-4-yl-1H-imidazol-2-yl derivatives 7, 8, 9 and their antiproliferative activities against A375P human melanoma cell line and WM3629 cell line were described. Most compounds showed superior antiproliferative activities compared to Sorafenib, the well-known RAF inhibitor. Among them, 7a exhibited potent activities on both cell lines (IC50 = 0.62 and 4.49 μM, respectively) and turned out to be a selective and potent CRAF inhibitor.

KW - Antiproliferative activity

KW - BRAF

KW - CRAF

KW - Melanoma cell line

KW - Pyrimidin-4-yl-1H-imidazol-2-yl derivatives

KW - Selectivity

UR - http://www.scopus.com/inward/record.url?scp=76649090272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76649090272&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2010.01.064

DO - 10.1016/j.bmcl.2010.01.064

M3 - Article

C2 - 20149658

AN - SCOPUS:76649090272

VL - 20

SP - 1573

EP - 1577

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 5

ER -

Access to Document